Tuesday, June 7, 2022
- 4:10pm-4:20pm
-
De-Novo Belatacept Therapy is Associated with an Increased Risk of Invasive CMV Disease After Kidney Transplantation
Kidney Immunosuppression • Hynes Room 302
- 4:10pm-4:20pm
-
Donors’ Perceptions of Uterus Donation Motivations, Informed Consent and Value: A Qualitative Study of Dallas Uterus Transplant Study (duets) Participants
VCA • Hynes Room 313
- 4:10pm-4:20pm
-
Dynamic Changes of Serum Soluble B Cell Activating Factor in Kidney Transplant with De Novo Donor Specific Antibody
- 4:10pm-4:20pm
-
Feasibility and Short-Term Outcomes of Kidney Transplantation Following Donation After Circulatory Death Using Thoracic Normothermic Regional Perfusion in the United States
Kidney Deceased Donor Selection II • Hynes Ballroom C
- 4:10pm-4:20pm
-
Financial Impact of a Culturally Sensitive Hispanic Kidney Transplant Program
Psychosocial and Treatment Adherence • Hynes Room 311
- 4:10pm-4:20pm
-
Heterogeneity in Center Practices in Liver Transplantation for Alcohol-Associated Liver Disease in the United States
Recipient Selection • Hynes Room 312
- 4:10pm-4:20pm
-
Pretransplant Recipient TNFR2+T Regulatory Cell Frequency Predicts Long-Term Outcomes After Kidney Transplantation
Biomarkers: Clinical Outcomes I • Hynes Veterans Auditorium
- 4:10pm-4:20pm
-
Recipient and Grafts Outcomes in Simultaneous Kidney and Pancreas Transplantation with Steroid Avoidance in the United States
Pancreas and Islet: All Topics • Hynes Room 210
- 4:10pm-4:20pm
-
T Cell-Specific CEACAM1 Alleviates Posttransplant Liver Injury via TIM-3 Inhibitory Regulation
Antigen Presentation and Costimulation • Hynes Room 309
- 4:20pm-4:30pm
-
Detection of CMV Mediated Sub-Clinical Rejection by Urine Biomarkers
Biomarkers: Clinical Outcomes I • Hynes Veterans Auditorium
- «Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 52
- Next Page»